MHC Class I Enables MSCs to Evade NK-Cell–Mediated Cytotoxicity and Exert Immunosuppressive Activity
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MHC Class I Enables MSCs to Evade NK-Cell–Mediated Cytotoxicity and Exert Immunosuppressive Activity
Authors
Keywords
-
Journal
STEM CELLS
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-07-19
DOI
10.1093/stmcls/sxac043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging understanding of apoptosis in mediating mesenchymal stem cell therapy
- (2021) Yu Fu et al. Cell Death & Disease
- Donor MSCs release apoptotic bodies to improve myocardial infarction via autophagy regulation in recipient cells
- (2020) Huan Liu et al. Autophagy
- Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients
- (2019) Tobias Deuse et al. NATURE BIOTECHNOLOGY
- Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
- (2019) Simona Sivori et al. Cellular & Molecular Immunology
- Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility
- (2019) Huaigeng Xu et al. Cell Stem Cell
- TNF-α/IL-1β–licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell–mediated induction of Foxp3+ regulatory T cells in the lung
- (2019) Nick Murphy et al. FASEB JOURNAL
- Mesenchymal stem versus stromal cells: International Society for Cellular Therapy Mesenchymal Stromal Cell committee position statement on nomenclature
- (2019) S. Viswanathan et al. CYTOTHERAPY
- The Importance of HLA Assessment in “Off-the-Shelf” Allogeneic Mesenchymal Stem Cells Based-Therapies
- (2019) Marta Kot et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An acute immune response underlies the benefit of cardiac stem-cell therapy
- (2019) Ronald J. Vagnozzi et al. NATURE
- CD8 + T cells and NK cells: parallel and complementary soldiers of immunotherapy
- (2018) Jillian Rosenberg et al. Current Opinion in Chemical Engineering
- Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs
- (2017) Darwin J. Prockop et al. MOLECULAR THERAPY
- HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
- (2017) Germán G Gornalusse et al. NATURE BIOTECHNOLOGY
- Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation
- (2017) Antonio Galleu et al. Science Translational Medicine
- MSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis
- (2017) Taeko Shigemoto-Kuroda et al. Stem Cell Reports
- Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart
- (2016) Xi-Ping Huang et al. FASEB JOURNAL
- Intraperitoneally infused human mesenchymal stem cells form aggregates with mouse immune cells and attach to peritoneal organs
- (2016) Nikolay Bazhanov et al. Stem Cell Research & Therapy
- Mesenchymal Stem/Stromal Cells Protect against Autoimmunity via CCL2-Dependent Recruitment of Myeloid-Derived Suppressor Cells
- (2015) Hyun Ju Lee et al. JOURNAL OF IMMUNOLOGY
- Mesenchymal stem/stromal cells precondition lung monocytes/macrophages to produce tolerance against allo- and autoimmunity in the eye
- (2015) Jung Hwa Ko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells
- (2015) Dachun Wang et al. Stem Cells Translational Medicine
- Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1
- (2015) Vanessa Kruse et al. PLoS One
- Mesenchymal stem cells: immune evasive, not immune privileged
- (2014) James A Ankrum et al. NATURE BIOTECHNOLOGY
- TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo
- (2014) Ryang Hwa Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells
- (2014) Justine Allard et al. Regenerative Medicine
- Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives
- (2014) Longmei Zhao et al. Stem Cell Research
- Dynamic compaction of human mesenchymal stem/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1)
- (2013) Thomas J. Bartosh et al. STEM CELLS
- Mesenchymal Stem Cell Lines Isolated by Different Isolation Methods Show Variations in the Regulation of Graft-versus-host Disease
- (2013) Hyun Seung Yoo et al. Immune Network
- Modulation of Human Mesenchymal Stem Cell Immunogenicity through Forced Expression of Human Cytomegalovirus US Proteins
- (2012) Melisa A. Soland et al. PLoS One
- Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF- B signaling in resident macrophages
- (2011) H. Choi et al. BLOOD
- Human Leukocyte Antigen I Knockdown Human Embryonic Stem Cells Induce Host Ignorance and Achieve Prolonged Xenogeneic Survival
- (2011) T. Deuse et al. CIRCULATION
- Therapeutic factors secreted by mesenchymal stromal cells and tissue repair
- (2011) Ryang Hwa Lee et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Exploitation of Herpesvirus Immune Evasion Strategies to Modify the Immunogenicity of Human Mesenchymal Stem Cell Transplants
- (2011) Anabel S. de la Garza-Rodea et al. PLoS One
- Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells
- (2010) Chiara Bocelli-Tyndall et al. ARTHRITIS AND RHEUMATISM
- Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair
- (2010) Xi-Ping Huang et al. CIRCULATION
- Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells
- (2010) Ralf Dressel et al. FASEB JOURNAL
- Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties
- (2010) T. J. Bartosh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6
- (2009) Ryang Hwa Lee et al. Cell Stem Cell
- Natural killer cells remember: An evolutionary bridge between innate and adaptive immunity?
- (2009) Joseph C. Sun et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started